International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)

NCT06174727 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2026-07-10

No results posted yet for this study

Summary

This multicenter retrospective cohort study aims to evaluate and compare the technical performance, safety, and clinical outcomes of intracranial aneurysms treated with flow diverter stents and endosaccular flow disruptors.

Conditions

  • Intracranial Aneurysm

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER
  • Sarasota Memorial Health Care System

    collaborator OTHER
  • Geisinger Health

    collaborator UNKNOWN
  • University at Buffalo

    collaborator OTHER
  • Thomas Jefferson University

    collaborator OTHER
  • University Health Network, Toronto

    collaborator OTHER
  • Munson Medical Center

    collaborator OTHER
  • HCA Houston Healthcare Kingwood

    collaborator UNKNOWN
  • University of Miami

    collaborator OTHER
  • Robert Wood Johnson University Hospital

    collaborator UNKNOWN
  • Lahey Hospital & Medical Center

    collaborator OTHER
  • Unity Health Toronto

    collaborator OTHER
  • Allina Health System

    collaborator OTHER
  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • David Altschul, MD · Montefiore Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-01
Primary Completion
2027-07-31
Completion
2027-07-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06174727 on ClinicalTrials.gov